Usefulness of cell-free and concentrated ascites reinfusion therapy in the therapeutic management of advanced ovarian cancer patients with massive ascites

被引：0
|
作者：
Yoshiko Kawata
Kazunori Nagasaka
Yoko Matsumoto
Katsutoshi Oda
Michihiro Tanikawa
Kenbun Sone
Mayuyo Mori-Uchino
Tetsushi Tsuruga
Takahide Arimoto
Yutaka Osuga
Tomoyuki Fujii
机构：
[1] The University of Tokyo,Department of Obstetrics and Gynecology, Faculty of Medicine
[2] Teikyo University School of Medicine,Department of Obstetrics and Gynecology
来源：
International Journal of Clinical Oncology | 2019年 / 24卷
关键词：
Cell-free and concentrated ascites reinfusion therapy; Advanced ovarian cancer; Body temperature; Ascites tumor cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：420 / 427
页数：7
相关论文
共 50 条
  • [31] Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1
    Yamaguchi, H.
    Kitayama, J.
    Emoto, S.
    Ishigami, H.
    Ito, T.
    Hanafusa, N.
    Watanabe, T.
    EJSO, 2015, 41 (07): : 875 - 880
  • [32] Feasibility, efficacy, and safety of cell-free and concentrated ascites reinfusion therapy (KM-CART) for malignant ascites
    Matsusaki, Keisuke
    Orihashi, Kazumasa
    ARTIFICIAL ORGANS, 2020, 44 (10) : 1090 - 1097
  • [33] Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
    Tsubokura, Misato
    Adegawa, Yuko
    Kojima, Minoru
    Tanosaki, Ryuji
    Ohtake, Ryuzaburo
    Kase, Yuki
    Iwashita, Nao
    Kasane, Moemi
    Nakabayashi, Saori
    Takeuchi, Sayaka
    Kato, Ken
    Boku, Narikazu
    Kanemitsu, Yukihide
    Okusaka, Takuji
    Fujimoto, Hiroyuki
    Yonemori, Kan
    Ishiki, Hiroto
    Kawamura, Kimihiko
    Satomi, Eriko
    Matsushita, Hiromichi
    BMC CANCER, 2022, 22 (01)
  • [34] Endotoxin Activity Reflects an Increase in Body Temperature in Cirrhotic Patients With Ascites Undergoing Cell-free and Concentrated Ascites Reinfusion Therapy
    Namisaki, Tadashi
    Tsuji, Yuki
    Kitade, Mitsuteru
    Yorioka, Nobuyuki
    Fujinaga, Yukihisa
    Sawada, Yasuhiko
    Nishimura, Norihisa
    Kitagawa, Koh
    Inoue, Takashi
    Takaya, Hiroaki
    Kaji, Kosuke
    Kawaratani, Hideto
    Moriya, Kei
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    IN VIVO, 2022, 36 (03): : 1477 - 1484
  • [35] Effects of cell-free and concentrated ascites reinfusion therapy (CART) on symptom relief of malignancy-related ascites
    Ito, Tetsuya
    Hanafusa, Norio
    Iwase, Satoru
    Noiri, Eisei
    Nangaku, Masaomi
    Nakagawa, Keiichi
    Miyagawa, Kiyoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (03) : 623 - 628
  • [36] Adverse effects of cell-free and concentrated ascites reinfusion therapy for malignant ascites: a single-institute experience
    Misato Tsubokura
    Yuko Adegawa
    Minoru Kojima
    Ryuji Tanosaki
    Ryuzaburo Ohtake
    Yuki Kase
    Nao Iwashita
    Moemi Kasane
    Saori Nakabayashi
    Sayaka Takeuchi
    Ken Kato
    Narikazu Boku
    Yukihide Kanemitsu
    Takuji Okusaka
    Hiroyuki Fujimoto
    Kan Yonemori
    Hiroto Ishiki
    Kimihiko Kawamura
    Eriko Satomi
    Hiromichi Matsushita
    BMC Cancer, 22
  • [37] Cell-Free and Concentrated Ascites Reinfusion Therapy Is More Effective for Refractory Ascites in Patients with Autosomal Dominant Polycystic Kidney Disease
    Kurihara, Shigekazu
    Suwabe, Tatsuya
    Yamanouchi, Masayuki
    Ubara, Yoshifumi
    Kamijo, Yuji
    Sawa, Naoki
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [38] Potential risks of cell-free concentrated ascites reinfusion therapy in TAFRO syndrome patient
    Satoh, Kasumi
    Okuyama, Manabu
    Nakae, Hajime
    THERAPEUTIC APHERESIS AND DIALYSIS, 2024, 28 (03) : 477 - 478
  • [39] Cell-free and Concentrated Ascites Reinfusion Therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal administration of Paclitaxel with Oral S-1
    Kitayama, Joji
    Ishigami, Hironori
    Yamaguchi, Hironori
    Hanafusa, Norio
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Feasibility of a fast-track randomized controlled trial of cell-free and concentrated ascites reinfusion therapy for patients with refractory malignant ascites
    Yokomichi, Naosuke
    Imai, Kengo
    Sakamoto, Masaki
    Horiki, Masashi
    Yamauchi, Toshihiro
    Miwa, Satoru
    Inoue, Satoshi
    Uneno, Yu
    Suzuki, Hidekazu
    Wada, Toru
    Ichikawa, Yuri
    Morita, Tatsuya
    BMC CANCER, 2022, 22 (01)
12345